Research  >  About SRI  >  Scientist Profiles
Share:  
|

Scientist profiles G-L

Sunnybrook Research Institute

Barbara Liu, MD, FRCPC

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room H4 79
Toronto, ON
M4N 3M5

Phone: 416-480-6766
Fax: 416-480-6068

Administrative Assistant: Laurie Kent
Phone:
416-480-6802
Fax:
416-480-6068

Education:

  • MD, 1987, faculty of medicine, University of Toronto, Canada
  • FRCPC, 1992, internal medicine, Royal College of Physicians and Surgeons of Canada
  • Diplomate, 1992, internal medicine, American Board of Internal Medicine, U.S.
  • FRCPC, 1993, geriatric medicine, Royal College of Physicians and Surgeons of Canada
  • Certificate, 1995, clinical pharmacology, U of T, Canada

Appointments and Affiliations:

  • Affiliate scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute
  • Executive director, Regional Geriatric Program of Toronto, Sunnybrook Health Sciences Centre
  • Associate professor, division of geriatric medicine, department of medicine, faculty of medicine, U of T
  • Cross appointment, division of clinical pharmacology, department of medicine, faculty of medicine, U of T
  • Consultant, geriatric medicine, Sunnybrook
  • Fellow, Royal College of Physicians of Edinburgh, U.K.

Research Focus:

  • Health services evaluation
  • Pharmacoepidemiology
  • Falls prevention

Research Summary:

Dr. Liu's research focuses on evaluation of interprofessional geriatric health services, appropriate medication use and falls prevention.

Selected Publications:

See current publications list at PubMed.

  1. Liu BA, Jackson LD.Drug prescribing in the older patient [Internet]. Philadelphia (PA): Physicians’ Information and Education Resource (U.S.); c2006. Available from: http://pier.acponline.org/physicians/diseases/d169.
  2. Liu BA, Juurlink DN. Drugs and the QT interval - caveat doctor. N Engl J Med. 2004 Sep;351(11):1053–6.
  3. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998 May;351(9112):1303–7.